NVIDIA Class Action | NVDA

On November 9, 2026, a securities class action complaint was filed against NVIDIA Corporation (“NVIDIA” or the “Company”) (NASDAQ: NVDA) and its CEO, Jen-Hsun “Jensen” Huang, on behalf of all persons and entities who purchased or otherwise acquired NVIDIA’s publicly-traded securities between October 9, 2025 and November 8, 2026, both dates inclusive (the “Class Period”).

The action, Kistenmacher v. NVIDIA Corporation, et al., was filed in the United States District Court for the Northern District of California and asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

NVIDIA Securities Class Action Allegations

According to the complaint, Defendants made false and/or misleading statements and/or failed to disclose that: 1) Jensen Huang had an affair with a suspected Chinese spy, who also has a role at a company called Megaspeed, which is suspected of helping China evade export controls; 2) as such, NVIDIA’s statements about its relationship with Megaspeed were materially false and misleading at all relevant times; 3) the foregoing raised concerns in the national security community about NVIDIA and, if revealed, presented a material risk to the Company’s reputation and business prospects; and 4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

NVIDIA Announces Board Investigation; Shares Decline

According to the complaint, on November 8, 2026, NVIDIA’s board announced that it was initiating an independent investigation following reports that Jensen Huang had been the target of a foreign intelligence effort. The board stated that it had no reason to believe that national security or NVIDIA secrets had been compromised and that independent directors, assisted by outside counsel, would oversee the inquiry.

According to the complaint, NVIDIA shares declined $7.97 per share, or 4.27%, to close at $178.67 on November 9, 2026.

January 8, 2027 Lead Plaintiff Deadline

NVIDIA investors have until January 8, 2027 to move the Court for appointment as lead plaintiff. Investors do not need to seek appointment as lead plaintiff to remain a member of the proposed class.

NVIDIA (NVDA) Investors: Contact Kehoe Law Firm

If you purchased NVIDIA securities during the Class Period and suffered financial losses, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to learn more about the class action and your legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

 

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Goosehead Insurance Securities Investigation | GSHD

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Goosehead Insurance, Inc. (“Goosehead” or the “Company”) (NASDAQ: GSHD) following the Company’s disclosure that previously issued financial statements dating back to 2023 should no longer be relied upon and must be restated.

After the market closed on November 9, 2026, Goosehead disclosed that on November 6, 2026, Goosehead’s Audit Committee concurred with management’s conclusion that the Company’s audited financial statements for fiscal years 2023, 2024 and 2025, and certain quarterly and year-to-date financial statements from 2023 through June 30, 2026, should no longer be relied upon and should be restated.

In response to an SEC comment letter received during a standard review of its annual filings, management determined that certain customer-contract commissions had been expensed rather than deferred and amortized, contrary to GAAP. A broader review identified an additional departure from GAAP involving certain technology-related and errors and omissions insurance program fees charged to franchisees, which were recorded as reductions of expenses rather than recognized as franchise revenues.

The Company also expects to report one or more material weaknesses in internal control over financial reporting and to conclude that its disclosure controls and procedures were not effective as of the end of each affected period. Further, Goosehead disclosed that it does not expect to file its third-quarter 2026 Form 10-Q on time because of the restatement.

Following the disclosure, Goosehead’s stock price declined nearly 14% in after-hours trading on November 9, 2026.

Goosehead (GSHD) Investors:

If you purchased or otherwise acquired Goosehead securities and suffered financial losses, you are encouraged to contact Kehoe Law Firm or Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

CVRx Class Action | CVRX

Did You Suffer Losses Investing in CVRx (CVRX)?

On November 9, 2026, a securities class action complaint was filed against CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) on behalf of persons and entities that purchased shares of CVRx common stock between July 25, 2023 and August 6, 2026, inclusive (the “Class Period”). 

The action, Oklahoma Police Pension and Retirement System v. CVRx, Inc., et al., was filed in the United States District Court for the District of Minnesota and asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

CVRx Securities Class Action Allegations

According to the complaint, defendants made materially false and/or misleading statements concerning CVRx’s financial results, business, operations, and compliance policies. The challenged statements concerned alleged illegal and unsustainable sales practices involving CVRX’s Barostim medical device, including improper marketing, offering or paying kickbacks, and providing false information to government health insurance programs in violation of the False Claims Act and Anti-Kickback Statute. The complaint further asserts that revenues were, in part, the product of such conduct and therefore unsustainable, and that the practices increased the risk of criminal and civil liability.

The complaint also challenges defendants’ statements about CVRx’s sales force realignment and commercial transformation. It asserts that turnover had not stabilized; productivity remained materially below expectations because the sales organization required additional training, support, and restructuring; and a significant portion of the sales force was inexperienced, required extended training and ramp time, and was not yet capable of generating the productivity needed to meet revenue projections.

CVRx Discloses DOJ Investigation and Cuts Outlook; Shares Decline

On August 6, 2026, after the market closed, CVRx filed a Form 10-Q disclosing that it had received a civil investigative demand from the U.S. Department of Justice on May 14, 2026, in connection with a False Claims Act investigation. The demand sought information concerning whether CVRx caused false claims to be submitted to government health insurance programs through improper device marketing, kickbacks to healthcare providers, or false information provided to those programs. The investigation does not establish that CVRx violated the law.

Also on August 6, 2026, CVRx reduced its outlook, citing, in part, weak sales force productivity. The Company disclosed that approximately 60% of its quota-carrying territory managers had joined during the preceding 18 months, straining onboarding and training processes, and identified sales force turnover and the slower pace at which new territory managers were becoming productive as primary factors behind the guidance update.

Following these disclosures, CVRx common stock declined $3.55 per share, or approximately 60%, from $5.94 per share on August 6, 2026 to close at $2.39 per share on August 7, 2026.

January 8, 2027 Lead Plaintiff Deadline

CVRx investors have until January 8, 2027 to move the Court for appointment as lead plaintiff. Investors do not need to seek appointment as lead plaintiff to remain a member of the proposed class.

CVRx (CVRX) Investors: Contact Kehoe Law Firm

If you purchased CVRx common stock during the Class Period and suffered financial losses, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to learn more about the class action and your legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kinross Gold Class Action | KGC

On November 6, 2026, a securities class action complaint was filed against Kinross Gold Corporation (“Kinross” or the “Company”) (NYSE: KGC) on behalf of all investors who purchased or otherwise acquired Kinross common stock between February 18, 2026 and September 23, 2026, inclusive (the “Class Period”).

The action, Lin v. Kinross Gold Corporation, et al., was filed in United States District Court for the District of Colorado and asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

Kinross Gold Securities Class Action Allegations

According to the complaint, defendants made materially false and/or misleading statements and concealed material adverse facts concerning Kinross’ production guidance. The complaint alleges that defendants repeatedly expressed confidence in production of approximately 2 million gold equivalent ounces annually for 2026 through 2028, while Kinross lacked the necessary resources and/or was otherwise ill-equipped to achieve those projections. The complaint further alleges that defendants minimized risks associated with continued production declines at Round Mountain Phase S and failed to adequately disclose risks associated with the mining equipment used at that operation.

Kinross Cuts Production Guidance; Shares Decline

On September 23, 2026, Kinross announced that it expected attributable production of approximately 1.84 million to 1.86 million gold equivalent ounces annually in 2026 and 2027, below its previously disclosed guidance. The Company attributed the reduction to extreme weather and operational challenges at La Coipa and Round Mountain, including lower mining rates, grades, and recoveries at Round Mountain Phase S. According to the complaint, Kinross subsequently discussed potential ore dilution associated with the use of larger mining equipment at Round Mountain.

Following the announcement, Kinross common stock declined $3.20 per share, or approximately 11.5%, from a closing price of $27.62 on September 23, 2026 to $24.42 on September 24, 2026.

January 5, 2027 Lead Plaintiff Deadline

Kinross Gold investors have until January 5, 2027 to move the Court for appointment as lead plaintiff. Investors do not need to seek appointment as lead plaintiff to remain a member of the proposed class.

Kinross Gold (KGC) Investors: Contact Kehoe Law Firm

If you purchased Kinross common stock during the Class Period and suffered financial losses, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to learn more about the class action and your legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

 

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Ionis Pharmaceuticals Securities Investigation | IONS

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Ionis Pharmaceuticals, Inc. (“Ionis” or the “Company”) (NASDAQ: IONS) following the Company’s November 9, 2026 announcement substantially reducing its full-year 2026 sales forecast for TRYNGOLZA (olezarsen).

On November 9, 2026, Ionis announced that it was lowering its 2026 TRYNGOLZA sales guidance from $100 million–$110 million to approximately $50 million, citing a slower-than-anticipated commercial launch.

Previously, Ionis had expressed confidence in TRYNGOLZA’s commercial launch and its ability to achieve the Company’s sales guidance. The November 9, 2026, disclosures raise questions concerning whether Ionis adequately disclosed adverse sales trends and commercialization challenges known to management during the third quarter.

Following the announcement, Ionis shares declined approximately 20% in premarket trading on November 9, 2026.

Ionis (IONS) Investors:

If you purchased or otherwise acquired Ionis securities and suffered financial losses, you are encouraged to contact Kehoe Law Firm or Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

MNTN Securities Investigation | MNTN

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of MNTN, Inc. (“MNTN” or the “Company”) (MNTN: NYSE) following the Company’s November 4, 2026 disclosures concerning sales force attrition, disappointing third-quarter results, and reduced financial guidance.

On August 4, 2026, MNTN announced its second-quarter financial results and provided third-quarter revenue guidance of $86 million to $89 million and adjusted EBITDA guidance of $22 million to $25 million. The Company also projected full-year 2026 revenue of $347 million to $357 million and adjusted EBITDA of $96 million to $101 million.

During the Company’s August 4 earnings conference call, then-CEO Mark Douglas discussed MNTN’s investments in its sales organization and described its products and go-to-market structure as: “ready to execute at greater scale.” Douglas also discussed the Company’s development of specialized, industry-focused sales teams, stating: “That knowledge makes our sales process and the customer experience more effective.”

On November 4, 2026, MNTN reported third-quarter revenue of approximately $80.3 million and adjusted EBITDA of approximately $19.9 million, both below the Company’s August guidance. MNTN also substantially lowered its full-year financial outlook, projecting revenue of approximately $311 million to $314 million and adjusted EBITDA of approximately $66 million to $68 million.

During the November 4 earnings conference call, newly appointed CEO Tony Weisman attributed the disappointing results to significant disruptions involving the Company’s sales organization. Weisman disclosed: “We lost about 40% of our experienced quota-carrying sellers”

Weisman further explained that changes to the Company’s sales structure and employee compensation arrangements contributed to the departures and adversely affected its ability to acquire new customers. Significantly, when discussing the timing of these changes, Weisman stated: “These were told to the team in late Q2”

On this news, MNTN’s stock proce closed down more than 54% on November 5, 2026.

MNTN (NYSE: MNTN) Investors:

If you purchased or otherwise acquired MNTN securities and suffered financial losses, you are encouraged to contact Kehoe Law Firm or Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]